IP Library › Granted Patent US 8,580,786
Granted Patent B2
US 8,580,786 · App. 12/971,786 · Granted Nov 12, 2013

Triazine derivatives and their therapeutical applications

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,580,786
App. No.
12/971,786
Granted
Nov 12, 2013
Kind
B2
Abstract

The invention provides for Triazine derivatives and their use to modulate protein kinase activity in a variety of conditions and diseases.

Claims (3)

1. A method for treating rheumatoid arthritis in a mammal comprising

(a) identifying the mammal afflicted with rheumatoid arthritis, and

(b) administering to said afflicted mammal a therapeutically effective amount of a composition comprising a compound or pharmaceutically acceptable form thereof selected from the group consisting of:

Assignments (4)
CHANGE OF NAME Recorded Oct 27, 2016
From: NANTBIO, INC.
To: NANTBIOSCIENCE, INC.
Reel/Frame 040505/0295 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 9, 2014
From: NANT HOLDINGS IP, LLC
To: NANTBIO, INC.
Reel/Frame 032635/0932 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 18, 2013
From: ABRAXIS BIOSCIENCE, INC.; ABRAXIS BIOSCIENCE, LLC
To: CALIFORNIA CAPITAL EQUITY, LLC
Reel/Frame 031229/0697 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 18, 2013
From: CALIFORNIA CAPITAL EQUITY, LLC
To: NANT HOLDINGS IP, LLC
Reel/Frame 031230/0335 →